<DOC>
	<DOCNO>NCT01747447</DOCNO>
	<brief_summary>The VITamin D OmegA-3 TriaL ( VITAL ; NCT 01169259 ) randomize clinical trial 25,874 U.S. men woman investigate whether take daily dietary supplement vitamin D3 ( 2000 IU ) fish oil ( 1 gram omega-3 fatty acid ) reduces risk develop cancer , heart disease , stroke people prior history illness . This ancillary study conduct among sub-cohort 773 participant VITAL test efficacy safety high-dose vitamin D supplementation vs. placebo skeletal health body composition .</brief_summary>
	<brief_title>VITamin D OmegA-3 TriaL : Effects Bone Structure Architecture</brief_title>
	<detailed_description>The VITAL : Effects Bone Structure Architecture ancillary study parent VITAL . This study enrol sub-cohort 773 VITAL participant NIH-sponsored Harvard Catalyst Clinical Translational Science Center ( CTSC ) . The following measurement perform baseline 2 year post-randomization determine whether high-dose vitamin D supplementation vs. placebo : 1 ) produce small increase reduce bone loss spine , hip , total body areal bone density assess dual x-ray absorptiometry ( DXA ) ; 2 ) reduces bone turnover assess biomarkers bone resorption formation ; 3 ) improves ( ) volumetric bone mineral density ( vBMD ) measure bone structure assess peripheral quantitative compute tomography ( pQCT ) ( b ) bone microarchitecture assess high resolution pQCT ( HR-pQCT ) distal radius tibia ; 4 ) result change body composition assess DXA . Parallel assessments effect omega-3 fatty acid perform . This study may elucidate mechanism high-dose vitamin D may prevent age-related fracture provide new insight role vitamin D skeletal health body composition .</detailed_description>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>Participants VITAL ( NCT 01169259 ) meet follow criterion eligible participate ancillary study : Those use bisphosphonates currently within past 2 year , boneactive medication currently within past year eligible study .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>